-
In March 2009, 89 active-duty u.s. trainees received yellow fever (YF) vaccination as part of standard preparation for potential travel to sub-Saharan Africa and Central and South America.
-
A retrospective observational study was conducted on 30 individuals from a possible 49 persons who were treated for schistosomiasis between 2003 and 2008 at Copenhagen University Hospital, Denmark.
-
This subset analysis from a larger prospective, multicenter HIV-HCV coinfection treatment trial found that patients receiving highly active antiretroviral therapy (HAART) in combination with pegylated interferon alfa and ribavirin for HCV were at greater risk for lactic acidosis and hyperlactatemia than those receiving HCV treatment alone.
-
In this issue: Lorcaserin submitted for FDA review, FDA advisory panel votes against phentermine/topiramate, mixed vote on rosiglitazone, advisory panel votes to remove breast cancer indication from bevacizumab labeling, no increase in seizures found with DTaP vaccine, new REMS for quinine.
-
-
Colistin (Ppolymyxin E) was isolated from bacillus colistinus 60 years ago and, during the 1960s, a new intravenous formulation (Coly-Mycin M Parenteral) became available for use in clinical practice.
-
Using liquid medium with a commercial air sampler, air was sampled at varying distances from 19 patients admitted to the hospital with Pneumocystis pneumonia. Samples were examined and DNA quantified using a real-time PCR assay targeting the large subunit ribosomal RNA gene.
-
Nasal carriage of mr-cons was prospectively investigated in 291 adults upon hospital admission.
-
-
Autochthonous transmission of dengue virus infection has been detected in Florida.
